{"disease":{"id":"acute-necrotizing-encephalopathy","name":"acute necrotizing encephalopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06731790","title":"Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05853159","title":"Clinical and Radiological Prognostic Factors of Acute Necrotizing Encephalopathy in Sohag University Hospital","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Sohag University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}